Quell Therapeutics Limited
Company 11890040 Active
Connected board network
The connection graph needs a free account.
This company's record is public. The network of who else its directors govern is compiled from the registers by us, and an account keeps it out of bulk scrapers.
Sign in, freeBoard DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Gaps to watch
- Narrow spread of sectors across the board
Where to look Suggested search: directors from a wider range of sectors.
Related organisations iRelated organisationsCompanies whose board overlaps with this one through the same people. Deterministic, from public records.
- SV Health Investors UK Limited 1 shared director
- Pulmocide Limited 1 shared director
- Mina Therapeutics Limited 1 shared director
- Acbd Limited 1 shared director
- Autifony Therapeutics Limited 1 shared director
- Mina Alpha Limited 1 shared director
Companies whose board overlaps with this one through the same people. Deterministic, from public records.
Company details
| Number | 11890040 |
| Status | Active |
| Type | Private Limited Company |
| Incorporated | 19/03/2019 |
| Address | 3RD FLOOR, TRANSLATION & INNOVATION HUB, 84 WOOD LANE, LONDON, W12 0BZ |
| Accounts next due | 30/09/2027 |
| Accounts last made up | 31/12/2025 |
Industry (SIC)
Ownership - persons with significant control (2)
- Syncona Limited
ownership of shares 25-50% voting rights 25-50% - Syncona Portfolio Limited ceased 2019
ownership of shares 50-75% voting rights 50-75%
Officers (14)
- Annette Clancy Director · appointed 2025
- Luke Matthew Beshar Director · appointed 2024
- Bingham, Catherine Elizabeth, Dame Director · appointed 2023
- Tyrell Jermaine Rivers Director · appointed 2023
- Jeffrey Stephen Long-Mcgie Director · appointed 2021
- Patel, Dhavalkumar D, Dr Director · appointed 2020
- Lechler, Robert Ian, Sir Director · appointed 2020
- Iain Robert Mcgill Director · appointed 2020
- Petris, Elisa Michela, Dr Director · appointed 2019
Show 5 former officers
- Ashrafian, Houman, Professor Director · appointed 2021 · resigned 2023
- Rachel Brooke Mears Director · appointed 2021 · resigned 2025
- Stephen Keith Rhind Director · appointed 2019 · resigned 2021
- Fueyo, Alberto Sanchez, Professor Director · appointed 2019 · resigned 2021
- Murphy, Martin Patrick, Dr Director · appointed 2019 · resigned 2023
Directors and officers on the Companies House record, current and former.
Report an error in this record - let us know.
Related record